Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
856 questions in 87 reviews · Cystic Fibrosis and Genetic Disorders
current versionsNo studies 856 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Tinzaparin vs placebo Number of serious complications of SCD ‐ not measured · people with sickle cell disease Low‐molecular‐weight heparins for managing vaso‐occlusive crises in people with sickle cell disease (2015) · Cochrane | no estimate extracted | NR | No studies |
Tinzaparin vs placebo Number of other sickle‐related events ‐ not measured · people with sickle cell disease Low‐molecular‐weight heparins for managing vaso‐occlusive crises in people with sickle cell disease (2015) · Cochrane | no estimate extracted | NR | No studies |
Tinzaparin vs placebo Quality of life (e.g. absence from school, lost time at work, mobility) as assessed by any validated questionnaire either generic or SCD specific) ‐ not measured · people with sickle cell disease Low‐molecular‐weight heparins for managing vaso‐occlusive crises in people with sickle cell disease (2015) · Cochrane | no estimate extracted | NR | No studies |
Tinzaparin vs placebo Participant satisfaction with the medication assessed by any appropriate and validated questionnaire (either generic or SCD specific) ‐ not measured · people with sickle cell disease Low‐molecular‐weight heparins for managing vaso‐occlusive crises in people with sickle cell disease (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Severe allergic reaction · persons with severe haemophilia A and factor inhibitory antibodies Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Nephrotic symdrome · persons with severe haemophilia A and factor inhibitory antibodies Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B (2014) · Cochrane | no estimate extracted | NR | No studies |